- CSR Summary Not Available
- NCT00553176
- Primary Citation
Trial Information
Generic NameN/AProduct NameREMICADE®Therapeutic AreaImmune System DiseasesEnrollment6273% Female58%% White89%
Product ClassAntirheumatic Agents - Biologic Response ModifiersSponsor Protocol NumberC0168Z01Data PartnerJohnson & JohnsonCondition StudiedCrohn's DiseaseMean/Median Age (Years)42.5
Supporting Documentation
- Collected Datasets Available
- Data Definition Specification Available
- Protocol with Amendments Available
- Clinical Study Report Available